Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity

Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity

The effects of androgens on cardiovascular disease (CVD) risk in men remain unclear. To better characterize the relationship between androgens and HDL, we investigated the effects of testosterone replacement on HDL protein composition and serum HDL-mediated cholesterol efflux in hypogonadal men. Twe...

Full description

Bibliographic Details
Main Authors:	Katya B. Rubinow, Tomas Vaisar, Chongren Tang, Alvin M. Matsumoto, Jay W. Heinecke, Stephanie T. Page
Format:	Article
Language:	English
Published:	Elsevier 2012-07-01
Series:	Journal of Lipid Research
Subjects:	cardiovascular disease lipoproteins lipids atherosclerosis androgens
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520345144

Similar Items

Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity[S]
by: Tomáš Vaisar, et al.
Published: (2015-08-01)

Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway[S]
by: Nathalie Pamir, et al.
Published: (2016-02-01)

Intestinal nuclear receptors in HDL cholesterol metabolism
by: Chiara Degirolamo, et al.
Published: (2015-07-01)

HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity
by: Mark S. Borja, et al.
Published: (2015-10-01)

The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties[S]
by: Anna Schwendeman, et al.
Published: (2015-09-01)

Serum, but not monocyte macrophage foam cells derived from low HDL-C subjects, displays reduced cholesterol efflux capacity
by: Shuhei Nakanishi, et al.
Published: (2009-02-01)

Visualizing caveolin-1 and HDL in cholesterol-loaded aortic endothelial cells
by: W.T. Chao, et al.
Published: (2003-06-01)

Spontaneous remodeling of HDL particles at acidic pH enhances their capacity to induce cholesterol efflux from human macrophage foam cells
by: Su Duy Nguyen, et al.
Published: (2012-10-01)

The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, lipolactonase stimulation, and cholesterol effluxs⃞
by: Leonid Gaidukov, et al.
Published: (2006-11-01)

Cholesterol efflux capacity, HDL cholesterol, and risk of coronary heart disease: a nested case-control study in men
by: Leah E. Cahill, et al.
Published: (2019-08-01)

Psoriasis alters HDL composition and cholesterol efflux capacity[S]
by: Michael Holzer, et al.
Published: (2012-08-01)

Genetic control of the mouse HDL proteome defines HDL traits, function, and heterogeneity[S]
by: Nathalie Pamir, et al.
Published: (2019-03-01)

Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I
by: Marie-Claude Blatter Garin, et al.
Published: (2006-03-01)

Cellular cholesterol efflux mediated by HDL isolated from subjects with low HDL levels and coronary artery disease
by: Luciana Uint, et al.
Published: (2003-07-01)

Beyond HDL-cholesterol increase: phospholipid enrichment and shift from HDL3 to HDL2 in alcohol consumers
by: Christian Schäfer, et al.
Published: (2007-07-01)

The HDL proteome: a marker–and perhaps mediator–of coronary artery disease
by: Jay W. Heinecke
Published: (2009-01-01)

Triglyceride/HDL-Cholesterol Ratio as an Index of Intracranial Atherosclerosis in Nonstroke Individuals
by: Min-Hee Woo, et al.
Published: (2021-01-01)

Age-related impairment of HDL-mediated cholesterol efflux
by: Hicham Berrougui, et al.
Published: (2007-02-01)

Overexpression and deletion of phospholipid transfer protein reduce HDL mass and cholesterol efflux capacity but not macrophage reverse cholesterol transport
by: Takashi Kuwano, et al.
Published: (2017-04-01)

The relationship between non-HDL cholesterol and macrophage phenotypes in human adipose tissue
by: Rudolf Poledne, et al.
Published: (2016-10-01)

The role of level and function of High Density Lipoprotein (HDL) in Cardiovascular Diseases
by: Malihe Aghasizadeh, et al.
Published: (2020-06-01)

Atomistic MD simulation reveals the mechanism by which CETP penetrates into HDL enabling lipid transfer from HDL to CETP
by: Geraldine Cilpa-Karhu, et al.
Published: (2015-01-01)

Targeted next-generation sequencing to diagnose disorders of HDL cholesterol
by: Singh N. Sadananda, et al.
Published: (2015-10-01)

ApoE-containing HDL and the development of atherosclerosis
by: Agnieszka Ćwiklińska, et al.
Published: (2015-01-01)

Association between plasma HDL-cholesterol concentration and Taq1B CETP gene polymorphism in non-insulin-dependent diabetes mellitus
by: Sophie Bernard, et al.
Published: (1998-01-01)

A meta-analysis of HDL cholesterol efflux capacity and concentration in patients with rheumatoid arthritis
by: Binbin Xie, et al.
Published: (2021-02-01)

LDL-apheresis depletes apoE-HDL and pre-β1-HDL in familial hypercholesterolemia: relevance to atheroprotection
by: Alexina Orsoni, et al.
Published: (2011-12-01)

Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis
by: Eftaxia-Konstantina Valanti, et al.
Published: (2018-10-01)

Effects of peroxisome proliferator-activated receptor α/δ agonists on HDL-cholesterol in vervet monkeys
by: Jeanne M. Wallace, et al.
Published: (2005-05-01)

Cholesterol efflux via HDL resecretion occurs when cholesterol transport out of the lysosome is impaireds⃞
by: Tamara A. Pagler, et al.
Published: (2007-10-01)

High-Density Lipoprotein (HDL) Triglyceride and Oxidized HDL: New Lipid Biomarkers of Lipoprotein-Related Atherosclerotic Cardiovascular Disease
by: Fumiaki Ito, et al.
Published: (2020-04-01)

Influence of HDL-cholesterol-elevating drugs on the in vitro activity of the HDL receptor SR-BI
by: Thomas J.F. Nieland, et al.
Published: (2007-08-01)

Therapies to Increase ApoA-I and HDL-Cholesterol Levels
by: William M. Brown, et al.
Published: (2008-01-01)

Characterization of phospholipids in pre-α HDL: selective phospholipid efflux with apolipoprotein A-I
by: Wenwu Zhang, et al.
Published: (1998-08-01)

Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol[S]
by: Laxman Yetukuri, et al.
Published: (2010-08-01)

HDL efflux capacity, HDL particle size, and high-risk carotid atherosclerosis in a cohort of asymptomatic older adults: the Chicago Healthy Aging Study
by: R.Kannan Mutharasan, et al.
Published: (2017-03-01)

Serum LDL- and HDL-cholesterol determined by ultracentrifugation and HPLC
by: Jun Dong, et al.
Published: (2011-02-01)

Origins of intestinal ABCA1-mediated HDL-cholesterol*
by: F. Jeffrey Field, et al.
Published: (2008-12-01)

Plasma kinetics of VLDL and HDL apoC-I in normolipidemic and hypertriglyceridemic subjects
by: Jeffrey S. Cohn, et al.
Published: (2002-10-01)

Lp(a)-cholesterol is associated with HDL-cholesterol in overweight and obese African American children and is not an independent risk factor for CVD
by: Sharma Sushma, et al.
Published: (2012-01-01)